[HTML][HTML] Liquid biopsy in hepatocellular carcinoma: where are we now?

F Pelizzaro, R Cardin, B Penzo, E Pinto, A Vitale… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the mostly lethal cancers, with a
prognosis which is still very poor. Novel reliable biomarkers, useful in early diagnosis and …

The role of liquid biopsy in hepatocellular carcinoma prognostication

I Labgaa, A Villanueva, O Dormond, N Demartines… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the deadliest cancer. Clinical
guidelines for the management of HCC endorse algorithms deriving from clinical variables …

[HTML][HTML] Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

E Roeb, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …

[HTML][HTML] Liquid biopsy in hepatocellular carcinoma: opportunities and challenges for immunotherapy

P Maravelia, DN Silva, G Rovesti, M Chrobok, P Stål… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) causes many deaths worldwide, and
current treatments have limitations. Immunotherapies have shown the most promising …

[HTML][HTML] Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German Society of Gastroenterology, digestive and …

F Tacke, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …

From liver cirrhosis to cancer: the role of micro-RNAs in hepatocarcinogenesis

R Mohr, B Özdirik, J Lambrecht, M Demir… - International journal of …, 2021 - mdpi.com
In almost all cases, hepatocellular carcinoma (HCC) develops as the endpoint of a
sequence that starts with chronic liver injury, progresses to liver cirrhosis, and finally, over …

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC

SH Loosen, M Castoldi, MS Jördens, S Roy, M Vucur… - Plos one, 2021 - journals.plos.org
Background Early detection of hepatocellular carcinoma (HCC), the most common primary
liver malignancy, is crucial to offer patients a potentially curative treatment strategy such as …

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

S Gonvers, P Tabrizian, E Melloul, O Dormond… - Frontiers in …, 2022 - frontiersin.org
Liver transplant (LT) is the most favorable treatment option for patients with early stage
hepatocellular carcinoma (HCC). Numerous attempts have been pursued to establish …

Novel biomarkers for monitoring and management of hepatocellular carcinoma

R Solhi, M Pourhamzeh, A Zarrabi, M Hassan… - Cancer Cell …, 2024 - Springer
Due to current challenges in the early detection, less than 40% of individuals diagnosed with
hepatocellular carcinoma (HCC) are viable candidates for surgical intervention. Therefore …

The challenges and potential in develo** microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and …

OD Tavabie, S Salehi, VR Aluvihare - Expert Review of Molecular …, 2024 - Taylor & Francis
Introduction Determining the need for liver transplantation remains critical in the
management of hepatocellular carcinoma (HCC) and liver failure syndromes (including …